<DOC>
	<DOC>NCT02486471</DOC>
	<brief_summary>Cytological abnormalities of the Cervix uteri need to be clarified by colposcopy biopsy. To avoid bleeding after biopsy, monsel´s paste is a common used Agent. In a randomized clinical Trial the use of monsel´s paste after biopsy will be compared to no Intervention. The Primary outcome of the study is blood loss, secondary outcomes are pain, satisfaction of the patient and influence of Independent factors such as Age and Body mass index.</brief_summary>
	<brief_title>Hemostatic Procedure After Biopsy of the Cervix</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>abnormal pap smear first colposcopy ever pregnancy bleeding disorder the use of blood thinner language barrier unwillingness to participate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>cervical dysplasia</keyword>
	<keyword>colposcopy</keyword>
	<keyword>haemostatic procedure</keyword>
	<keyword>biopsy of the cervix uteri</keyword>
</DOC>